Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

RAB9 Recombinant Antibody, APC Conjugated

Product Specifications

Background

Involved in the transport of proteins between the endosomes and the trans Golgi network. Involved in the recruitment of SGSM2 to melanosomes and is required for the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes.

Synonyms

RAB9A; DmRab9; Ras related protein Rab 9A.

Gene ID

9367

Swiss Prot

P51151

Cellular Locus

Cytoplasm, Cell membrane

Host

Rabbit

Cross Reactivity

Human, Mouse, Rat

Target

RAB9

Clonality

Recombinant

Conjugation

APC

Source

KLH conjugated synthetic peptide derived from human Rab9A

Applications

WB

Purification

Purified by Protein A.

Excitation Emission

650nm/660nm

Concentration

Lot dependent

Dilution

WB (1:300-5000)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Gene ID URL

9367

Isotype

IgG

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Lesabelimab (Biosimilar Reference Antibody) (PDL1)
RA0604-01 100 µg

Lesabelimab (Biosimilar Reference Antibody) (PDL1)

Ask
View Details
Lesabelimab (Biosimilar Reference Antibody) (PDL1)
RA0604-02 1 mg

Lesabelimab (Biosimilar Reference Antibody) (PDL1)

Ask
View Details
Lesabelimab (Biosimilar Reference Antibody) (PDL1)
RA0604-03 5 mg

Lesabelimab (Biosimilar Reference Antibody) (PDL1)

Ask
View Details
Lesabelimab (Biosimilar Reference Antibody) (PDL1)
RA0604-04 10 mg

Lesabelimab (Biosimilar Reference Antibody) (PDL1)

Ask
View Details
Lesabelimab (Biosimilar Reference Antibody) (PDL1)
RA0604-05 25 mg

Lesabelimab (Biosimilar Reference Antibody) (PDL1)

Ask
View Details
Lesabelimab (Biosimilar Reference Antibody) (PDL1)
RA0604-06 50 mg

Lesabelimab (Biosimilar Reference Antibody) (PDL1)

Ask
View Details